News
18hon MSN
Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...
Major pharmaceutical manufacturing company Eli Lilly is considering a $5.7 billion investment into a facility in Houston.
Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing ...
Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord ...
Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.
With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...
Eli Lilly has spent the last several years reintroducing itself to the public via a series of corporate campaigns. | Eli Lilly has spent the last several years reintroducing itself to the public via a ...
Eli Lilly and Co. and Purdue University announced Friday that Lilly will invest $250 million in a collaboration between the two over the next eight years. Lilly’s investment is intended to accelerate ...
The stock should perform well beyond 2030 thanks to its impressive innovative abilities. With a constellation of ...
Pharma giant Eli Lilly may plant a $5.9 billion manufacturing facility in Houston’s Generation Park, bringing serious biotech ...
investors who buy the stock and park it in their portfolios for good will eventually be glad they did so. Prosper Junior Bakiny has positions in Eli Lilly and Novo Nordisk. The Motley Fool has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results